FREMONT, Calif., Feb. 25, 2025 -- Ultima Genomics, Inc., developer of the UG100™ next-generation sequencing (NGS) platform, today announced expanded global access to high-quality, low-cost DNA sequencing with the addition of multiple new partnerships with leading genomic services providers. This global network of well-known service providers will offer industry-leading DNA sequencing services utilizing the UG 100 in support of single cell sequencing, spatial transcriptomics, proteomics, whole genome sequencing, and other applications. The world-class organizations announced today include Broad Clinical Labs, Eurofins, Novogene, Psomagen, and Ontario Institute of Cancer Research. These new partners join existing Ultima Genomics service provider partners Macrogen, Inocras, and the University of Minnesota Genomics Center.
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
